Twist Bioscience Corp
NASDAQ:TWST

Watchlist Manager
Twist Bioscience Corp Logo
Twist Bioscience Corp
NASDAQ:TWST
Watchlist
Price: 29.3 USD 1.42% Market Closed
Market Cap: 1.7B USD

Relative Value

The Relative Value of one TWST stock under the Base Case scenario is 53.65 USD. Compared to the current market price of 29.3 USD, Twist Bioscience Corp is Undervalued by 45%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

TWST Relative Value
Base Case
53.65 USD
Undervaluation 45%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
88
vs Industry
49
Median 3Y
7.7
Median 5Y
9.8
Industry
6.9
Forward
4.6
vs History
vs Industry
Median 3Y
-9.7
Median 5Y
-11.8
Industry
23
Forward
-13.2
vs History
vs Industry
Median 3Y
-16
Median 5Y
-22.8
Industry
19.7
vs History
vs Industry
Median 3Y
-9.9
Median 5Y
-19.5
Industry
22.8
vs History
57
vs Industry
16
Median 3Y
3.1
Median 5Y
5.1
Industry
2.6
vs History
84
vs Industry
42
Median 3Y
6.2
Median 5Y
8.4
Industry
7.4
Forward
3.9
vs History
88
vs Industry
30
Median 3Y
16.3
Median 5Y
20.2
Industry
9.3
vs History
vs Industry
Median 3Y
-8.6
Median 5Y
-12
Industry
4.1
Forward
-17.3
vs History
vs Industry
Median 3Y
-7.6
Median 5Y
-10.4
Industry
4.1
Forward
-10.5
vs History
vs Industry
Median 3Y
-12.6
Median 5Y
-19.7
Industry
4.9
vs History
vs Industry
Median 3Y
-7.9
Median 5Y
-16.8
Industry
3.6
vs History
61
vs Industry
24
Median 3Y
3.9
Median 5Y
6.2
Industry
4.7

Multiples Across Competitors

TWST Competitors Multiples
Twist Bioscience Corp Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Twist Bioscience Corp
NASDAQ:TWST
1.7B USD 5 -9.1 -8.7 -7.4
FR
Pharnext SCA
OTC:PNEXF
6T USD 34 873 287.2 -165 747.6 -201 270.4 -198 973.7
US
Abbvie Inc
NYSE:ABBV
328.7B USD 5.7 79.1 15.1 22.3
US
Amgen Inc
NASDAQ:AMGN
155B USD 4.5 26.1 14.1 23.3
US
Gilead Sciences Inc
NASDAQ:GILD
137B USD 4.8 23 10 13.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
113.6B USD 10.2 -114.9 24.4 25.5
US
Epizyme Inc
F:EPE
94.1B EUR 2 020.1 -515.5 -561.3 -546.4
AU
CSL Ltd
ASX:CSL
119.6B AUD 5.1 28 17.3 21.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
53B USD 3.8 11.8 10.4 11.7
US
Seagen Inc
F:SGT
39.3B EUR 19.5 -59.7 -64.3 -58
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
39.7B USD 16.9 -147.2 -658.7 -330.1
P/E Multiple
Earnings Growth PEG
US
Twist Bioscience Corp
NASDAQ:TWST
Average P/E: 33.6
Negative Multiple: -9.1
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -165 747.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
79.1
88%
0.9
US
Amgen Inc
NASDAQ:AMGN
26.1
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
23
188%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -114.9 N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -515.5 N/A N/A
AU
CSL Ltd
ASX:CSL
28
16%
1.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
11.8
7%
1.7
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.7 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -147.2 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Twist Bioscience Corp
NASDAQ:TWST
Average EV/EBITDA: 15.2
Negative Multiple: -8.7
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -201 270.4 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.1
13%
1.2
US
Amgen Inc
NASDAQ:AMGN
14.1
17%
0.8
US
Gilead Sciences Inc
NASDAQ:GILD
10
6%
1.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.4
17%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -561.3 N/A N/A
AU
CSL Ltd
ASX:CSL
17.3
11%
1.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
10.4
11%
0.9
US
S
Seagen Inc
F:SGT
Negative Multiple: -64.3 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -658.7 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Twist Bioscience Corp
NASDAQ:TWST
Average EV/EBIT: 19.7
Negative Multiple: -7.4
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -198 973.7 N/A N/A
US
Abbvie Inc
NYSE:ABBV
22.3
29%
0.8
US
Amgen Inc
NASDAQ:AMGN
23.3
32%
0.7
US
Gilead Sciences Inc
NASDAQ:GILD
13.8
11%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.5
17%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -546.4 N/A N/A
AU
CSL Ltd
ASX:CSL
21.6
14%
1.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
11.7
11%
1.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -58 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -330.1 N/A N/A